Half Year Results 

Healthcare slowdown at Wilmington

Healthcare slowdown at Wilmington

Wilmington’s (WILM) top-line growth was buoyed by the acquisition of Health Service Journal last January, but revenues contracted by 3 per cent on an underlying basis. This stemmed from the discontinuation of the group's legal practice support business, together with delays in its compliance unit, and a slowdown in the UK pharmaceutical area of the healthcare division. The information service provider’s shares were marked down in response to the news.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now